You have searched for "biomedical"
Showing 1-10 of 525
LONDON (Reuters): On Friday, Feb. 21, Duncan Selbie, chief executive of Public Health England, was in a cheerful mood. It was near the end of the school half-term holiday.
PARIS (Reuters) - French drugmaker Sanofi SA said on Tuesday it expects to get approval for the potential COVID-19 vaccine it is developing with Britain's GlaxoSmithKline Plc by the first half of next year, faster than previously anticipated.
KUALA LUMPUR: Malaysia's success in controlling the spread of Covid-19 challenges the idea that medical expertise and a robust health system “is best channeled by legacy powers and historically rich states”, says a report.
WASHINGTON (Reuters) - A senior U.S. Army vaccine researcher said on Tuesday it was reasonable to expect that some sort of coronavirus vaccine could be available to part of the U.S. population by the end of the year.
KINSHASA (Reuters) - Democratic Republic of Congo declared a new Ebola epidemic on Monday in the western city of Mbandaka, more than 1,000 km (620 miles) away from an ongoing outbreak of the same deadly virus in the east.
SUNWAY University is in discussions with the University of Cambridge, United Kingdom, to collaborate on ways to tackle the Covid-19 pandemic.
(Reuters) - U.S. President Donald Trump's administration awarded a contract worth up to $812 million for a new U.S. company to manufacture drugs and drug ingredients to fight COVID-19 on American soil, aiming to end dependence on other countries.
(Reuters) - Moderna Inc's experimental COVID-19 vaccine, the first to be tested in the United States, produced protective antibodies in a small group of healthy volunteers, according to very early data released by the biotech company on Monday.
CHICAGO/SYDNEY (Reuters) - Global coronavirus deaths passed 300,000 on Thursday as infections approached 4.5 million, according to a Reuters tally, with the United States responsible for more than a quarter of all fatalities.